Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.

James H Stein, Joseph L Witztum, Curt D Furberg, Ronald B Goldberg, Barbara V Howard, Michael Davidson, John D Brunzell

Journal: Diabetes care 2008;31(4):811-22

PMID: 18375431

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

Address: Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, and the Northwest Lipid Laboratory, University of Washington, Seattle, Washington, USA.

DOI: 10.2337/dc08-9018

Link outs

Free resources

Medical:

https://medlineplus.gov/diabetestype2.html

Other Literature Sources:

https://www.lens.org/lens/search/patent/list?q=ref...

Subscription / membership required

Full Text Sources:

MeSH Terms: Cardiovascular Diseases, Cholesterol, LDL, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Humans, Lipoproteins, Risk Factors, Societies, Medical, United States, Voluntary Health Agencies